What Changes for Dermatology Billing in 2026

Dermatology billing in 2026 requires compliance with new CPT codes, revised Medicare reimbursement rates, and updated ICD-10-CM classifications. Practices must adapt to the Centers for Medicare & Medicaid Services’ final rule, which introduces conversion factors of $33.57 for qualifying APM participants and $33.40 for non-qualifying participants, along with a 2.5% efficiency adjustment affecting procedural codes.

The American Medical Association released more than 400 CPT code modifications, effective January 1, 2026. These changes affect skin biopsies, lesion-destruction procedures, and skin-substitute applications. Dermatology practices face revenue pressure due to inadequate implementation of these updates.

How Do CPT Code Updates Affect Dermatology Practices?

CPT code changes in 2026 directly impact billing accuracy and reimbursement rates. The destruction codes for skin lesions now distinguish between different methods and lesion types. Practices must document the specific technique used, including cryosurgery, electrosurgery, laser surgery, or chemical therapy.

Skin biopsy codes 11102-11107 require precise documentation of lesion size before anesthesia administration. The tangential biopsy code 11102 applies to the first lesion, while 11103 covers each additional lesion. Missing pathology reports for codes 88304-88305 trigger claim denials. Documentation must specify specimen type and note if special stains or immunohistochemistry were used.

Lesion destruction follows the 17000 series codes. CPT 17000 covers the first premalignant lesion, CPT 17003 applies to lesions two through 14, and CPT 17004 addresses 15 or more lesions. Practices must accurately count lesions and link each claim to the appropriate diagnosis code. Vague documentation leads to downcoding and compliance risks.

What Medicare Reimbursement Changes Impact Revenue?

Medicare reimbursement in 2026 presents mixed results for dermatology practices. The conversion factor increased from $32.35 to either $33.57 or $33.40, depending on participation in the alternative payment model. This represents a 3.77% increase for qualifying participants and 3.26% for non-qualifying participants.

CMS implemented a 2.5% efficiency adjustment to work relative value units for non-time-based services. This adjustment applies to most dermatological procedures. The combination of the higher conversion factor and the efficiency adjustment may result in net payment reductions for procedure-heavy practices.

Dermatology practices that rely on procedures such as excisions, Mohs surgery, and lesion destruction could experience a 5-15% revenue reduction without mitigation strategies. Commercial payers often use Medicare rates as baseline benchmarks, extending the impact beyond Medicare patients.

How Should Practices Handle Skin Substitute Policy Changes?

Skin substitutes in 2026 are classified as incident-to supplies rather than biologicals. Medicare now pays a single national rate of approximately $127.28 per square centimeter, rather than using the average sales price methodology. This represents up to a 90% reduction in reimbursement for certain advanced wound products, such as amniotic membranes.

Practices must map each product to its HCPCS code and regulatory category. Products licensed as biologics under Section 351 continue receiving payment under the ASP method. Documentation requirements include ulcer type, precise size measurements with photographs, duration, conservative care provided, treatment intervals, and response to therapy.

Prior authorization tracking becomes essential in 2026. Many products require renewed authorization linked to treatment stages or wound improvement. Authorization delays can halt patient treatment and prevent reimbursement entirely. Billing teams should maintain up-to-date tracking systems with renewal-date notifications.

What ICD-10-CM Updates Require Attention?

ICD-10-CM codes for 2026 include 630 new codes effective October 1, 2025. Dermatology-specific updates provide expanded classifications for psoriasis subtypes, eczema variations, and actinic keratosis categories. Code L30.9 covers unspecified dermatitis, while L98.8 and L98.9 address other specified and unspecified skin disorders.

Specificity in diagnosis coding directly affects claim acceptance rates. Generic codes such as R23.9 for unspecified skin changes should be avoided when more specific options are available. Screening code Z12.83 applies to malignant neoplasm screening encounters. Proper code selection prevents denials and supports medical necessity documentation.

How Can Practices Avoid Common Billing Mistakes?

Modifier 25 usage faces increased scrutiny in 2026. This modifier indicates a separately identifiable evaluation and management service on the same day as a procedure. Documentation must clearly demonstrate that the E/M service was distinct from the procedural work. Payers audit modifier 25 claims aggressively, requiring thorough documentation supporting the separate service’s medical necessity.

The G2211 add-on code for complex E/M services receives heightened payer attention. Practices must document long-term patient relationships or complex medical decision-making to support this code. Generic statements about visit complexity fail during audits.

Global period violations create frequent denials. Practices must track surgical procedures with 10-day or 90-day global periods. Services included in the global package cannot be billed separately. Modifier 59 clarifies when distinct procedures are performed on the same day.

What Documentation Standards Must Be Met?

Documentation Quality: Essential for claim success in 2026.

Mohs Surgery Requirements:

• Must include stage-by-stage details.
• Document margin information.
• Outline specimen handling procedures.
• Each surgical stage should be documented separately with clear descriptions.

Lesion Measurements:

• Measure lesions before excision to support CPT code selection.
• Record size in centimeters, including margins when applicable.

Depth Documentation: Important for biopsy code selection.

Photographic Evidence:

• Use photographs to strengthen claims during audits.
• Provide visual evidence of lesion characteristics.

Medical Necessity Justification:

• Explain why the procedure was necessary in every service note.
• Reference clinical findings and diagnosis supporting the procedure.

Time-Based Coding:

• Document start and stop times or total time spent.
• Avoid vague statements like “appropriate time spent” which do not support code selection.

How Should Practices Implement Compliance Strategies?

Regular staff training on 2026 updates prevents costly errors. Training should cover new CPT codes, modifier usage, documentation requirements, and payer-specific policies. Quarterly reviews keep teams informed about mid-year updates and policy clarifications.

Coding audits identify patterns of under-coding or modifier misuse. External auditors provide objective assessments of billing accuracy. Internal reviews should examine the top 20 CPT codes quarterly and compare documentation against coding guidelines.

Technology solutions streamline compliance. Electronic health record templates with pre-set fields for lesion size, method, margins, and closure type ensure consistent documentation. Automated claim edits catch common errors before submission. Real-time eligibility verification prevents authorization issues.

Practices should analyze denial trends weekly. Track denial reasons related to documentation deficiencies, authorization gaps, or code pairing errors. Patterns reveal training needs and process improvements. Average accounts receivable should remain under 45 days through efficient billing practices.

Conclusion

Dermatology billing compliance in 2026 demands proactive adaptation to CPT code changes, Medicare reimbursement adjustments, and enhanced documentation standards. Practices that invest in staff training, implement regular audits, and leverage technology solutions will minimize denials and maintain revenue stability. The efficiency adjustment and skin substitute reclassification require strategic planning to offset financial impacts. Accurate coding, thorough documentation, and systematic compliance monitoring protect practices from audit risk while ensuring appropriate reimbursement for services provided.

Struggling with dermatology billing compliance? Partner with our expert medical billing team to maximize reimbursements and reduce claim denials.

FAQs

1. What is the Medicare conversion factor for dermatology in 2026?

The Medicare conversion factor for 2026 is $33.57 for qualifying APM participants and $33.40 for non-qualifying participants.

2. Which CPT codes changed for dermatology in 2026?

Skin biopsy codes 11102-11107, lesion destruction codes 17000-17004, and skin substitute application codes changed effective January 1, 2026.

3. How many new ICD-10-CM codes were added for dermatology?

630 new ICD-10-CM codes were added effective October 1, 2025, including expanded classifications for psoriasis, eczema, and actinic keratosis.

4. What documentation is required for Modifier 25 in dermatology billing?

Documentation must clearly demonstrate the E/M service was separately identifiable and distinct from the procedural work performed on the same day.